Barclays' Andrew Mok: Any sustained underperformance in big tech will likely benefit healthcare
Andrew Mok, Barclays director of equity research, joins CNBC's 'The Exchange' to discuss why healthcare may offer opportunity as tech stocks are under pressure from China competition.
